MedTrace Logo

Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers

NCT04366180 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 314

Last updated 2020-04-30

No results posted yet for this study

Summary

The aim of the present study is to evaluate the effects of Lactobacillus coryniformis K8 consumption on the incidence and severity of Covid-19 in health workers exposed to the virus. This is a preventive study

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic

The probiotic group will received one capsule with Lactobacillus K8 per day (3x10\^9 cfu/day) during 2 months

DIETARY_SUPPLEMENT

Control

The control group will received one placebo capsule per day during 2 months

Sponsors & Collaborators

  • Biosearch S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-24
Primary Completion
2020-06-30
Completion
2020-10-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04366180 on ClinicalTrials.gov